1. Lenalidomide plus rituximab (R2) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial. (28th March 2019) Authors: Becnel, Melody R.; Nastoupil, Loretta J.; Samaniego, Felipe; Davis, Richard E.; You, M. J.; Green, Michael; Hagemeister, Fredrick B.; Fanale, Michelle A.; Fayad, Luis E.; Westin, Jason R.; Wang, Michael; Oki, Yasuhiro; Forbes, Sheryl G.; Feng, Lei; Neelapu, Sattva S.; Fowler, Nathan H. Journal: British journal of haematology Issue: Volume 185:Number 5(2019) Page Start: 874 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗